Pharma giant GlaxoSmithKline will lay off 99 employees at its manufacturing facility in Memphis, Tenn., according to the Commercial Appeal.
The layoffs, set to take place between Dec. 10 and April 2, are a result of a contract manufacturing agreement ending in January.
After the layoffs, 160 employees will remain at the facility, according to a company spokesperson.
"We have a loyal and committed workforce at our Memphis site, and this decision is no reflection on the team or their performance," Glaxo spokesperson Caryn Previdi told the Commercial Appeal. "Teams at the Memphis site have demonstrated a great level of commitment to the business, and we very much appreciate their dedication and hard work."